The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Effective treatment of aggressive B-cell lymphomas by downregulated NIK-induced noncanonical NF-κB pathway activation through inhibition of BAFF.
Sung Hsin Kuo
No relevant relationships to disclose
Li-Tzong Chen
No relevant relationships to disclose
Kun-Huei Yeh
No relevant relationships to disclose
Hui-Jen Tsai
No relevant relationships to disclose
Hsiao-Wei Lee
No relevant relationships to disclose
Ann-Lii Cheng
No relevant relationships to disclose